Literature DB >> 30905417

Gender dysphoria and XX congenital adrenal hyperplasia: how frequent is it? Is male-sex rearing a good idea?

Lisieux Eyer de Jesus1, Eduardo Corrêa Costa2, Samuel Dekermacher3.   

Abstract

INTRODUCTION: The frequency of gender dysphoria (GD) among 46,XX congenital adrenal hyperplasia (CAH) patients is unknown. These data are needed to put into perspective the debate about the timing of reconstructive surgery and possible male-raising of the most severely virilized children.
OBJECTIVE: To analyze the frequency of female to male GD between 46,XX individuals raised as females; to identify subgroups with higher chances of showing GD; to describe the results of male-raising among 46,XX CAH patients.
MATERIALS AND METHODS: Analytic/descriptive literature review (January 1988 to April 2018).
RESULTS: Female-raised patients frequently report the desire to be male, adopt male-typical behavior and are frequently homosexual/bisexual as adults, but this does not correspond to GD. Declared GD among 46,XX CAH patients attained 9% of the reported cohorts, generally in late adolescence/adulthood. We could not prove a relationship between inadequate treatment, null-genotype, late diagnoses, a higher degree of virilization, type of CAH or higher levels of androgens and female to male GD, but this may be due to statistical limitations. Male gender raised patients (MGR) were 10.1% of CAH cohorts included in this review, mostly from underdeveloped countries, with a high proportion of late diagnoses (76.3%) and familial choices. GD was more common in this group than among female-raised patients. Opting for male gender relates to a short final height, the need for multiple surgeries, surgical castration before puberty and infertility.
CONCLUSION: Both male to female and female to male GD may present in 46,XX CAH patients in a contemporaneous cohort. The proportion of GD is higher among patients raised as males. DSD patients sexual maladjustments are complex and not comparable to the transgender population. Many 46,XX CAH patients with GD define themselves as gender-fluid and do not seek for legal/formal transition. Male-raising Prader 4/5 46,XX CAH patients imply infertility and multiple surgeries. There is no proof that any subgroup of CAH is more prone to GD, despite null genotypes, salt wasting phenotypes and Prader 4/5 cases being related to male-typical behavior and female homosexuality. TYPE OF STUDY: Descriptive/analytic non-systematic REVIEW. LEVEL OF EVIDENCE: 3.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital adrenal hyperplasia; DSD; Gender dysphoria

Mesh:

Year:  2019        PMID: 30905417     DOI: 10.1016/j.jpedsurg.2019.01.062

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Multidimensional Aspects of Female Sexual Function in Congenital Adrenal Hyperplasia: A Case-Control Study.

Authors:  Maggie Dwiggins; Brittany Brookner; Kylie Fowler; Padmasree Veeraraghavan; Veronica Gomez-Lobo; Deborah P Merke
Journal:  J Endocr Soc       Date:  2020-09-04

2.  Fully Masculinized 46,XX Individuals with Congenital Adrenal Hyperplasia: Perspective Regarding Sex of Rearing and Surgery.

Authors:  Collin L Jones; Christopher P Houk; Jr Ubirajara Barroso; Peter A Lee
Journal:  Int J Fertil Steril       Date:  2022-05-08

3.  Care of the adolescent patient with congenital adrenal hyperplasia: Special considerations, shared decision making, and transition.

Authors:  Reeti Chawla; Meilan Rutter; Janet Green; Erica M Weidler
Journal:  Semin Pediatr Surg       Date:  2019-09-20       Impact factor: 2.754

Review 4.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

5.  Compliance Issues in Managing 21 Hydroxylase Deficiency and their Short/Long-Term Consequences.

Authors:  Jack Lin; Teck K Khoo; Erin R Voelschow; Zachary J Viets
Journal:  Eur J Case Rep Intern Med       Date:  2021-11-30

Review 6.  Toward Improving the Transition of Patients With Congenital Adrenal Hyperplasia From Pediatrics to Adult Healthcare in Japan.

Authors:  Kei Takasawa; Kenichi Kashimada
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

7.  Syrian females with congenital adrenal hyperplasia: a case series.

Authors:  Nada Dehneh; Rami Jarjour; Sahar Idelbi; Assad Alibrahem; Sahar Al Fahoum
Journal:  J Med Case Rep       Date:  2022-10-15

8.  Gender-role behaviour and gender identity in girls with classical congenital adrenal hyperplasia.

Authors:  Sumudu Nimali Seneviratne; Umesh Jayarajah; Shamaali Gunawardana; Malik Samarasinghe; Shamya de Silva
Journal:  BMC Pediatr       Date:  2021-06-05       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.